Hi aboo: No one, nowhere is promoting MPL as a cure, the point being made is the mismanagement of market sensitive information. The OLE may not be an official trial but PAA (MT) have made a point that they would be using and announcing results and information from the OLE to progress MPL both with the FDA and the market (think SP).
The corollary of that is the market should be kept informed of any market sensitive information of which survival is paramount.
I am astounded at the devaluation of the company for no apparent reason other than the resignation of MT an event that could have been managed by the board (remember they have done nothing to mitigate the negative market fallout).
I find it hard to believe that anyone could disagree with that.
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1255
-
- There are more pages in this discussion • 170 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.015(7.32%) |
Mkt cap ! $97.90M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 23.0¢ | 21.5¢ | $443.1K | 2.052M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 120200 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 124358 | 3 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |